Breaking News, Financial News

Thermo Fisher Scientific

Acquisitions help with revenue growth

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific 4Q10 4Q Revenues: $2.8 billion (-2%) 4Q Earnings: $298 million (+9%) FY Revenues: $10.8 billion (+7%) FY Earnings: $1.0 billion (+22%) Comments: Analytical Technologies revenues were $1.2 billion for 4Q10 (+4%) and $4.6 billion for FY (+11%). Laboratory Products and Services were -6% for 4Q10 ($1.7 billion) and +4% for FY ($6.7 billion). Acquisitions accounted for 3% of FY revenue growth and 2% of 4Q10 revenue growth. The company predicts revenue growth of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters